Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
57.05
-0.06 (-0.11%)
Nov 8, 2024, 4:00 PM EST - Market closed

Soleno Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Selling, General & Admin
72.713.489.8410.818.766.93
Upgrade
Research & Development
65.7725.1915.2721.4523.1916.27
Upgrade
Operating Expenses
138.4738.6725.1132.2631.9523.2
Upgrade
Operating Income
-138.47-38.67-25.11-32.26-31.95-23.2
Upgrade
Interest & Investment Income
10.832.580.30.110.010.15
Upgrade
Earnings From Equity Investments
------0.48
Upgrade
Other Non Operating Income (Expenses)
0.47-0.180.030.5111.64-6.96
Upgrade
EBT Excluding Unusual Items
-127.17-36.27-24.78-31.64-20.3-30.49
Upgrade
Other Unusual Items
-4-2.710.710.73-4.34-0.29
Upgrade
Pretax Income
-131.16-38.99-24.07-30.91-24.64-30.77
Upgrade
Earnings From Continuing Operations
-131.16-38.99-24.07-30.91-24.64-30.77
Upgrade
Net Income
-131.16-38.99-24.07-30.91-24.64-30.77
Upgrade
Net Income to Common
-131.16-38.99-24.07-30.91-24.64-30.77
Upgrade
Shares Outstanding (Basic)
38168542
Upgrade
Shares Outstanding (Diluted)
38168542
Upgrade
Shares Change (YoY)
271.22%96.40%57.90%27.39%83.41%62.77%
Upgrade
EPS (Basic)
-3.47-2.36-2.87-5.81-5.90-13.52
Upgrade
EPS (Diluted)
-3.47-2.36-2.87-5.81-5.90-13.52
Upgrade
Free Cash Flow
-51.63-24.94-20.79-27.79-25.23-17.4
Upgrade
Free Cash Flow Per Share
-1.36-1.51-2.48-5.23-6.04-7.64
Upgrade
EBITDA
-136.5-36.71-23.15-30.3-30-21.24
Upgrade
D&A For EBITDA
1.971.961.961.961.951.96
Upgrade
EBIT
-138.47-38.67-25.11-32.26-31.95-23.2
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.